New hope for advanced nose and throat cancer with combo therapy
NCT ID NCT07258979
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new drug (YL201) combined with an immunotherapy (toripalimab), with or without chemotherapy (cisplatin), in people whose nasopharyngeal cancer has come back or spread. The goal is to see if the combination is safe and helps control the cancer. About 202 adults with advanced disease will take part.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT OR METASTATIC NASOPHARYNGEAL CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
Affiliated Cancer Hospital and Institute of Guangzhou Medical University
NOT_YET_RECRUITINGGuangzhou, Guangdong, China
-
Chongqing University Cancer Hospital
NOT_YET_RECRUITINGChongqing, Chongqing Municipality, China
-
Dongguan People's Hospital
NOT_YET_RECRUITINGDongguan, Guangdong, China
-
Fudan University Shanghai Cancer Center
NOT_YET_RECRUITINGShanghai, Shanghai Municipality, China
-
Fujian Cancer Hospital
NOT_YET_RECRUITINGFuzhou, Fujian, China
-
Guangxi Medical University Cancer Hospital
NOT_YET_RECRUITINGNanning, Guangxi, China
-
Hunan Cancer Hospital
NOT_YET_RECRUITINGChangsha, Hunan, China
-
Jiangmen Central Hospital
NOT_YET_RECRUITINGJiangmen, Guangdong, China
-
Jiangxi Cancer Hospital
NOT_YET_RECRUITINGNanchang, Jiangxi, China
-
Sichuan Cancer Hospital
NOT_YET_RECRUITINGChengdu, Sichuan, China
-
Sun Yat-sen University Cancer Center
RECRUITINGGuangzhou, Guangdong, China
-
The First Affiliated Hospital of Guangdong Pharmaceutical University
NOT_YET_RECRUITINGGuangzhou, Guangdong, China
-
The First Affiliated Hospital of Hainan Medical University
NOT_YET_RECRUITINGHaikou, Hainan, China
-
The First Affiliated Hospital of Nanchang University
NOT_YET_RECRUITINGNanchang, Jiangxi, China
-
The First Affiliated Hospital of Xiamen University
NOT_YET_RECRUITINGXiamen, Fujian, China
-
The Second Affiliated Hospital of Guilin Medical University
NOT_YET_RECRUITINGGuilin, Guangxi, China
-
Yuebei People's Hospital
NOT_YET_RECRUITINGShaoguan, Guangdong, China
-
Yunnan Cancer Hospital
NOT_YET_RECRUITINGKunming, Yunnan, China
-
Zhangzhou Municiple Hospital of Fujian Province
NOT_YET_RECRUITINGZhangzhou, Fujian, China
-
Zhejiang Cancer Hospital
NOT_YET_RECRUITINGHangzhou, Zhejiang, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New drug combo targets Hard-to-Treat nasopharyngeal cancer
- New hope for tough nasopharyngeal cancer: Triple-Drug combo trial launches
- Two-Antibody combo takes on advanced cancers
- New drug shows promise for Hard-to-Treat throat cancer
- New cocktail of drugs shows promise for Hard-to-Treat throat cancer
- New drug cocktail aims to outdo chemo for tough throat cancer